SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as investors gear up for a major announcement following the project's integration with Stellar for global payroll infrastructure. The community is actively debating the potential for further high-profile partnerships, such as with Ripple, while monitoring the project's long-term utility and adoption as it nears 100,000 holders.

Derive is a decentralized protocol that creates programmable onchain options, perpetuals, and structured products.   Derive is deployed and operates on Derive Chain, an Ethereum rollup built using the OP stack and is the home of the Derive Protocol. It is a permission-less smart contract platform.  The Derive DAO earns trading fees from the Derive Protocol and gas fees from the Derive Chain, governed by DRV token holders. Trading fees accrue to an insurance fund to foster robustness of the protocol and rollup.  Derive has built an AI-powered trading app built for pro traders. In collaboration with Messari, Derive Pro translates market views into trades. The agent then prepares transactions for users and leverages smart contract wallets to make trades one-click, gasless and chainless. The app will support spot, perps and options trading on Derive, and will also plug in to spot AMMs on L2s like Optimism, Arbitrum and Base.

Derive

Derive is gaining significant momentum and community attention following a strategic collaboration with Synthetix to develop derivatives on the Ethereum network. Investors are actively discussing the protocol's healthy consolidation patterns, consistent upward price movement, and the potential impact of its ongoing buyback mechanism.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is actively trending as investors monitor the transition to new CEO Josh D'Amaro, with community discussion highlighting both optimism around potential content slate hits like the new Pixar film and skepticism regarding the company's long-term management and linear media headwinds. Sentiment remains divided, as traders debate whether the stock represents a deep-value opportunity at current levels or a persistent underperformer struggling with debt and content strategy.

Portillo's, Inc. serves street food through high-energy, multichannel restaurants designed to ignite the senses and create a memorable dining experience. The company was founded on June 8, 2021 and is headquartered in Oak Brook, IL.

Portillos Inc - Ordinary Shares - Class A

Portillo's is trending as investors debate whether the current valuation near all-time lows represents a deep-value opportunity or a sign of deeper structural decline. While the community remains divided over management's expansion strategy and the lack of a permanent CEO, sentiment is being bolstered by strong physical traffic at new locations and the belief that the stock is oversold due to end-of-year tax loss harvesting.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers Outdoor is trending as investors weigh strong brand momentum from HOKA and UGG against concerns over retail sector headwinds and the ongoing uncertainty surrounding tariff policies. While the community actively debates whether the stock is a long-term growth opportunity at current levels, sentiment remains split between those tracking technical chart resets and those bullish on potential earnings upside.

Kohl's Corp. engages in the operation of family-oriented department stores. Its business line includes apparel, footwear, and accessories for women, men, and children, home products, beauty products, and accessories. The stores generally carry a consistent merchandise assortment with some differences attributable to regional preferences. The company was founded in 1962 and is headquartered in Menomonee Falls, WI.

Kohl`s Corp.

Kohl's Corp

Kohl's is experiencing significant volatility and high short interest, with investors closely monitoring potential buyout rumors, real estate valuation plays, and the impact of tariff-related litigation on its bottom line. Market sentiment is sharply divided, as traders debate whether the stock's recent price swings represent a sustainable turnaround fueled by operational improvements and cost-cutting or a vulnerable 'value trap' susceptible to ongoing retail sector headwinds.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is experiencing heightened market attention as traders debate the sustainability of its rapid price appreciation, which many attribute to heavy involvement from major institutional holders and aggressive short-interest dynamics. While bullish sentiment is fueled by speculation regarding potential buyouts and successful corporate turnarounds, a significant segment of the community remains skeptical, citing weak fundamentals and labeling the current price action as market manipulation.

Oxford Lane Capital Corp. is a closed-end management investment company, which engages in investing in debt and equity tranches of collateralized loan obligation vehicles. The company was founded on June 9, 2010 and is headquartered in Greenwich, CT.

Oxford Lane Capital Corp

Oxford Lane Capital is experiencing significant volatility and negative sentiment, driven by a combination of disappointing quarterly earnings, a substantial 50% dividend cut, and a sharp decline in NAV. While some in the community argue these moves are necessary to stabilize the fund and position it for future growth, many investors remain skeptical, expressing frustration over persistent share price declines and the erosion of their initial capital.

Abacus Global Management, Inc. is a pioneering alternative asset manager specializing in uncorrelated financial products that leverage proprietary longevity data and actuarial technology. It operates through the following business segments: Asset Management, Life Solutions and Technology Services. The Asset Management segment provides asset management services primarily to institutional investors, as well as private clients, investing in uncorrelated longevity-based assets, fixed-income replacement strategies, and free cash flow–based investment solutions. The Life Solutions segment is engaged in the buying, selling, and trading of policies, as well as maintaining policies until the receipt of death benefits. The Technology Services segment provides real-time mortality verification, missing participant verification, and other life insurance–specific services to customers on a contract basis. The company was founded by Matthew Ganovsky, Kevin Scott Kirby, and Todd Sean McNealy in 2004 and is headquartered in Orlando, FL.

Abacus Global Management Inc. - Ordinary Shares - Class A

Abacus Global Management is attracting investor attention following a series of strong quarterly financial performances, a recent strategic move to acquire a stake in Manning & Napier, and the announcement of a capital allocation program. The community is actively discussing the company's vertical integration strategy, potential for long-term growth, and the perceived disconnect between its record operational results and stock price movements.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is garnering significant community attention as investors debate its potential role in the surging AI data center market, particularly following the introduction of standardized 12.5 MW power blocks. While some shareholders express frustration over persistent fundamental headwinds and limited contract announcements compared to peers like Bloom Energy, others remain optimistic that the company's modular technology and strategic alignment with key partners like ExxonMobil position it to capture long-term upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

8,437 Shares in Neurocrine Biosciences, Inc. $NBIX Acquired by Nilsine Partners LLC

Nilsine Partners LLC purchased a new position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the...

Neurocrine Biosciences, Inc. $NBIX Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 11.2% during the 4th quarter, according to its most recent filing with...

Wealth Enhancement Advisory Services LLC Boosts Stake in Neurocrine Biosciences, Inc. $NBIX

Wealth Enhancement Advisory Services LLC grew its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 33.1% in the 4th quarter, according to its most recent disclosure...

SG Americas Securities LLC Buys 119,339 Shares of Neurocrine Biosciences, Inc. $NBIX

SG Americas Securities LLC increased its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 785.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 134,530 shares of the compan...

Nordea Investment Management AB Increases Stake in Neurocrine Biosciences, Inc. $NBIX

Nordea Investment Management AB boosted its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 81.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 27,202 shares of the company's stock after acquiring an additional 12,195 shares...

Assenagon Asset Management S.A. Has $11.35 Million Stock Position in Neurocrine Biosciences, Inc. $NBIX

Assenagon Asset Management S.A. raised its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 70.4% in the fourth quarter, according to the company in its most recent...

Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings

Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings Neurocrine Biosciences Presents First Expert Consensus Recommendations for...

CIBC Private Wealth Group LLC Grows Stock Position in Neurocrine Biosciences, Inc. $NBIX

CIBC Private Wealth Group LLC boosted its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 17,250.0% during the third quarter, according to the company in its most recent...

Neurocrine Biosciences, Inc. $NBIX Shares Sold by Hudson Bay Capital Management LP

Hudson Bay Capital Management LP decreased its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 47.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,510 shares of the company's st...

Neurocrine Biosciences Maps 2026 Execution, Data-Rich 2027; Ingrezza Guides $2.7B $2.8B

Neurocrine Biosciences (NASDAQ:NBIX) executives used a conference discussion to frame 2026 as a year of execution ahead of what they described as a data-rich 2027 across multiple mid- and late-stage...

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Neurocrine Biosciences, Inc.

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$131.60
Prev Close	$132.56
Open	$130.81
Dividend Yield	0.00%
50-Day Moving Average	$131.92
Beta	0.75
Avg. Volume	994,323.26
PE Ratio	28.19

52-Week High	$160.18
52-Week Low	$84.23
Market Capitalization	$13.21B
EPS (Annual)	$4.67
Price to Book	4.05
Revenue Per Employee	$1.43M

NBIX
Neurocrine Biosciences, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NBIX News

NBIXNeurocrine Biosciences, Inc.